Good Health Can’t Wait, Says Dr. Reddy’s
Dr. Reddy’s launches new patient-centric branding at CPhI.
Dr. Reddy’s Laboratories is launching its new visual identity and branding rooted in the belief that “good health can’t wait” at CPhI Worldwide 2015. The purpose of the rebranding was to communicate the company’s transformation from an API manufacturer into a patient-centric multinational pharma player. Dr. Reddy’s is seeking to accelerate access to affordable and innovative medicines for people in need.
Medicines have a key role in enabling good health and improving quality of life. Dr. Reddy’s new branding and heart logo reflect this belief and reinforce the company’s pledge to provide tomorrow’s healthcare solutions today.
Dr. Reddy’s Active Ingredients and Custom Pharma Services (CPS) arms support global pharma companies in their quest to accelerate delivery of medicinal therapies. CPS offers manufacturing services and solutions for starting materials, intermediates, active ingredients, and finished dosage form. Partners have access to the company’s expertise and technologies (e.g., peptides, chirals, HPAPIs, steroids, activated mPEGs) as well as a global delivery network and intermediate and API portfolio.
Source: Dr. Reddy’s, Booth 6D30
Diving Deep into Carrier-Based Formulation and Process Optimization
December 23rd 2024Carrier-based formulations for dry powder inhalers are carefully designed to transport extremely small particles into the lungs. Jet milling can be used to micronize these particles, with both high and low shear mixing processes used to formulate mixtures capable of carrying the fine API particles into the deep lung. This paper looks at the requirements for pulmonary delivery via carrier-based inhaled powder formulations, and how jet milling can be used to manufacture effective and stable materials for these formulations
